Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Abiraterone Acetate
×
1 year
×
Clear all
Filters
3
NCT03834519
2025-05-18
KEYLYNK-010
Merck Sharp & Dohme LLC
Phase 3
Completed
793 enrolled
23 charts